Stoke Therapeutics, Inc. (STOK) Earnings Per Share, Basic USD/shares 2021 - 2024

Historical data

Taxonomy & unit: us-gaap: USD/shares
Description: The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary: Stoke Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2021 to 2024.
Stoke Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending March 31, 2024 was -0.57 USD/shares, a 7.55% decline year-over-year.
Stoke Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending March 31, 2024 was -2.42 USD/shares, a 2.02% increase year-over-year.
Stoke Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -2.38 USD/shares, a 8.46% increase from 2022.
Stoke Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -2.6 USD/shares, a 11.1% decline from 2021.

Earnings Per Share, Basic, Trailing 12 Months (USD/shares)

Earnings Per Share, Basic, Quarterly (USD/shares)

Earnings Per Share, Basic, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q1 2024	-$2	-$1	$0	-7.55%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-06
Q4 2023	-$2	-$1	+$0.04	+6.15%	Oct 1, 2023	Dec 31, 2023	10-K	2024-03-25
Q3 2023	-$2	-$1	+$0.11	+16.7%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-07
Q2 2023	-$3	-$1	$0	-9.52%	Apr 1, 2023	Jun 30, 2023	10-Q	2023-08-07
Q1 2023	-$2	-$1	+$0.13	+19.7%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-06
Q4 2022	-$3	-$1			Oct 1, 2022	Dec 31, 2022	10-K	2024-03-25
Q3 2022		-$1	$0	-8.2%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-07
Q2 2022		-$1	$0	-5%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-07
Q1 2022		-$1			Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-04
Q3 2021		-$1			Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-14
Q2 2021		-$1			Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-08

* An asterisk sign (*) next to the value indicates that the value is likely invalid.